Concepedia

Cris Roxas

CR

Statistics

Publications

13

Citations

923

H-Index

13

Active since

2020

Affiliations

King's College London(Current)

Guy's and St Thomas' NHS Foundation Trust

St. James's Hospital

Trinity College Dublin

Guy's Hospital

Cris Roxas is an author at King's College London specializing in eosinophilic disorders, pharmacotherapy, and pharmacotherapy for eosinophilic asthma.

Publications per year

2020–2025

13

Publications

13

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

Joanne Kavanagh, A Hearn, Jaideep Dhariwal et al. · CHEST Journal · 2020 · 260 citations

, , +12

Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma

Joanne Kavanagh, G d’Ancona, Maria Elstad et al. · CHEST Journal · 2020 · 204 citations

, , +12

Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma

G d’Ancona, Joanne Kavanagh, Cris Roxas et al. · European Respiratory Journal · 2020 · 86 citations · Full text

, , +17

The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

A Hearn, Joanne Kavanagh, G d’Ancona et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 66 citations

, , +10

Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma

Joanne Kavanagh, A Hearn, G d’Ancona et al. · Allergy · 2020 · 50 citations · Full text

, , +15

1–5 of 13